If you’re looking to stay up to date with the latest commercialization news out of the Office of Research and Technology Management at ÐÓ°ÉÊÓƵ, you’ve come to the right place. Explore some of our latest headlines relating to inventions, startups and more from researchers at CWRU.
2025
Trailhead Biosystems | May 6, 2025
BioSpace | April 29, 2025
The Daily | April 25, 2025
=
The Daily | April 11, 2025
WATE | April 10, 2025
NutraIngredients USA | April 7, 2025
Labiotech | April 7, 2025
Crain’s Cleveland Business | April 3, 2025
Global NewsWire | March 24, 2025
PR Newswire | March 11, 2025
Trailhead Biosystems | March 5, 2025
BusinessWire | Feb. 11, 2025
NervGen | Feb. 6, 2025
PR Newswire | Feb. 5, 2025
Crain’s Cleveland Business | Jan. 17, 2025
Energy.gov | Jan. 8, 2025
2024
University Hospitals | Dec. 17, 2024
Forbes | Dec. 11, 2024
Global NewsWire | Nov. 14, 2024
PR Newswire | Oct. 29, 2024
FreshWater | Oct. 24, 2024
NutraIngredients USA | Oct. 16, 2024
PR Newswire | Sept. 26, 2024
MetroHealth | Sept. 9, 2024
PR Newswire | Aug. 28, 2024
News 5 Cleveland | Aug. 22, 2024
University Hospitals | Aug. 9, 2024
The Daily | July 12, 2024
NervGen | June 25, 2024
DefiniGEN | June 3, 2024
Crain’s Cleveland Business | March 18, 2024
PR Newswire | March 7, 2024
Crain’s Cleveland Business | Feb. 20, 2024
The Daily | Feb. 19, 2024
BusinessWire | Feb. 1, 2024
The Daily | Jan. 5, 2024
2023
Amgen.com | Nov. 28, 2023
The Daily | Nov. 15, 2023
Luciddx.com | Oct. 31, 2023
Nervgen.com | Oct. 23, 2023
Nervgen.com | Sept. 25, 2023
Bioinformant | Sept. 18, 2023
Cleveland.com | July 25, 2023
Crain's Cleveland Business | July 11, 2023
PAVmed | May 11, 2023
AUTM | April 21, 2023
PAVmed | April 18, 2023
NervGen | April 13, 2023
Cleveland.com | April 5, 2023
NervGen | March 30, 2023
NutraIngredients USA | March 16, 2023
Cleveland.com | March 15, 2023
The Daily | March 8, 2023
The Business Journal Daily | March 8, 2023
The Daily | Feb. 23, 2023
Crain's Cleveland Business | Feb. 23, 2023
PAVmed | Feb. 15, 2023
The Daily | Feb. 14, 2023
NervGen | Feb. 14, 2023
The Daily | Feb. 13, 2023
Fox 8 WJW | Feb. 7, 2023
Forbes | Jan. 27, 2023
The Plain Dealer | Jan. 26, 2023
Ideastream Public Media | Jan. 26, 2023
Drug Discovery and Development | Jan. 18, 2023
The Daily | Jan. 17, 2023
2022
Lucid Diagnostics | Dec. 8, 2022
The Daily | Dec. 8, 2022
Lucid Diagnostics | Dec. 1, 2022
Exclusive license agreement with ÐÓ°ÉÊÓƵ for Core-NK platform
Chimeric Therapeutics | Nov. 21, 2022
PAVmed | Dec. 1, 2022
PAVmed | Dec. 8, 2022
The Daily | Dec. 8, 2022
The Daily | Nov. 21, 2022
Ohio Department of Development | Oct. 18, 2022
NervGen | Oct. 25, 2022
The Daily | Sept. 14, 2022
The Daily | Sept. 8, 2022
The Daily | Sept. 8, 2022
The Daily | Sept. 9, 2022
Folio Photonics Announces Breakthrough Multi-Layer Optical Disc Storage Technology to Enable Industry-Disruptive Cost, Cybersecurity and Sustainability Benefits
Folio Photonics | Aug. 30, 2022
PAVmed | Aug. 11, 2022
NervGen | Aug. 10, 2022
Lucid Diagnostics | Aug. 4, 2022
BusinessWire | Aug. 3, 2022
NervGen | Aug. 2, 2022
PAVmed | Aug. 2, 2022
NervGen | July 14, 2022
RAD adds brain tumor technology to portfolio
Radiopharm Theranostics | June 9, 2022
The Daily | May 25, 2022
AccessWire | May 12, 2022
PAVmed | May 9, 2022
PAVmed | April 4, 2022
NervGen Presenting Interim Phase 1 Clinical Trial Data for NVG-291 at the 2022 American Academy of Neurology Annual Meeting
NervGen | March 31, 2022
PAVmed | March 24, 2022
PAVmed | March 23, 2022
NervGen | March 15, 2022
PAVmed | March 3, 2022
The Daily | Feb. 11, 2022
The Daily | Jan. 27, 2022
News 5 Cleveland | Jan. 21, 2022
The Daily | Jan. 20, 2022
Crain's Cleveland Business | Jan. 20, 2022
Crain's Cleveland Business | Jan. 19, 2021
The Daily | Jan. 5, 2022